Valion Bio (VBIO) Non-Current Assets (2021 - 2026)
Valion Bio (VBIO) posted Non-Current Assets of $29.09 million for Q2 2026, up 991.2% from $2.67 million a year earlier.
Powered by 
Analysis
Valion Bio (VBIO) Non-Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Valion Bio's Non-Current Assets came in at $18.6 million.
- Annual Non-Current Assets shows a four-year compound annual growth rate of 123.4% (FY2021 to FY2025).
- In prior years, Valion Bio's Non-Current Assets was $168,000 in FY2024 (-66.7%), $505,000 in FY2023 (-11.2%), $569,000 in FY2022 (-23.8%) and $747,000 in FY2021.
- The Q2 2026 figure stands as the highest quarterly Non-Current Assets in data going back to Q4 2021.
- On a year-over-year basis, Non-Current Assets increased in three of the last five quarters, with growth averaging 458.4%.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q2 2026, with growth of 991.2%; the weakest was Q2 2024, with a decline of 79.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Valion Bio | 378,559.99 | -19.06 Mn | - | 29.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.09 Mn |
| Dec 31, 2025 | 18.60 Mn |
| Sep 30, 2025 | 2.49 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Dec 31, 2024 | 168,000.00 |
| Sep 30, 2024 | 231,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 459,000.00 |
| Dec 31, 2023 | 505,000.00 |
| Sep 30, 2023 | 552,000.00 |
| Jun 30, 2023 | 596,000.00 |
| Mar 31, 2023 | 619,000.00 |
| Dec 31, 2022 | 569,000.00 |
| Sep 30, 2022 | 614,000.00 |
| Jun 30, 2022 | 654,000.00 |
| Mar 31, 2022 | 696,000.00 |
| Dec 31, 2021 | 747,000.00 |
API Access
Valion Bio Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();